Sertificate of Registration GMP/LE/2004/002 Sertificate of Registration ISO 9001:2000 Sertificate of Registration ISO 9001:2000
Choose
your language:
English Russian
Choose the firm:
 Registrations
 Our partners
 Contact Us
 Search
 Price
For registered users
login
password
    
featured products
    Glucose 5%
    Cipro-Tech
    Iono-Tech
    Manni-Tech 10%
    Metronidazole 0.5%
    NaCl 0.9%
    Rheopolyglucinum
    Ringer
    Solutio Novocaini 0.25%
    Natrii citrati 4%
    Diprosalic Lotion 30 ml
    Freederm Shampoo Tar 150 ml
    Intron 18 miu 3ml 1 vial
    Triderm Cream 15 g
    Augmentin tab. 375mg N20
    Augmentin inj. 600mg N1
    Dermovate Oint 25g Tube
    Imigran Tab. 50mg N2
    Levitra 5mg 2 tab
    Mylogin Caps 250mg N10
    Mylogin Caps 250mg N20
    Oxybral Caps 30mg N20
    Septrin Paed Susp 100ml N1
    Valtrex tab. 500mg N10
    Vitamax Caps N5
    Zantac Tab. 150mg N20
    Zeffix Tab 100mgx28
    Zinacef Inj 750mg N1
    Zofran Tab 4mg N10
    Zyban 150 mg tabs. X 60
    Wellbutrin SR 150mg 60 tab
    Astmopent Aer 400Ds 0.75mg
    Salbutamol inh
information about product

HAEMODESUM-PHARMATECH
(Intravenous Solution for injection)

The trading (patented) name of a preparation - HAEMODESUM-PHARMATECH
The international name -
- Polyvinylpyrrolidone
ATC-CODE- B05AA07

THE COMPOSITION AND THE FORM OF RELEASE
1 litre of a solution contains
Polyvinylpyrrolidone ..... 60 g
Sodium Cloride ............. 5.50 g
Potassium Cloride ............... 0.42 g
Calcium Cloride ............ 0.56 g
Magnesium Cloride ............ 0.005 g
Sodium Hydrocarbonate ... 0.23 g
Other components: water for an injection.
200, 250, 400, 500 ml of soltuion in plastic PVC containers.


PHARMACOLOGICAL EFFECT
It's effect is caused by the ability low-molecular polyvinylpyrrolidone to connect toxins, which circulates in blood, and quickly removes them from the organism. The preparation increases diuresis.

INDICATIONS FOR ADMINISTRATION
Administered during detoxication at toxic forms of gastroenteric diseases (salmonellosis, dysentery, etc.), including children. Intoxications of a various origin (cancer, beam, postoperative, alcoholic, an intoxication resulting from renal insufficiency), burns in the stage of intoxication, peritonitis, septic conditions, toxicosis during preganancy and other pathological processes, accompanied by intoxication.

DOSIAGE
Haemodesum is administered intravenously with controlled rate 40-80 drop/min. For adults single dose up to 300-500 ml. For children up to 5-10 ml / kg. Repeated injections are made by 12 hour intervals and more at the end of the previous injection. The number of application and the overall amount of infused Haemodesum is dependant on the pathologic(al) process. Its administration mostly patients with heavy health conditions should be under doctor's control.

PREGNANCY AND THE LACTATION
Contra-indications are not revealed.

SPECIAL INDICATIONS/B>
Before the administration of the solution warm up to +35 - +37 oC.

STORAGE CONDITIONS AND SHELF LIFE
The preparation should be stored in usual conditions at temperature +0-+ 20 oC. Freezing does not render any influence on the quality of a preparation. Expiry date - 3 years.

  Copyright © 2006 PharmaTech